Using a crossover , double-blind , placebo-controlled design , 21 participants ( 10 women , mean age 26.9 , range 20-37 years ) received sumatriptan and 22 participants ( 11 women , mean age 25.5 , range 22-32 years ) received acetylsalicylic acid ( ASA ) .